Overall, FBXO7 copy number losses are more prevalent than gains, as shallow and deep deletions occur in 32.5% (169 of 526 cases) and <0.2% (1 of 526) of CRC cases, respectively, while gains and amplifications only occur in 4% (19 of 526) and <0.2% (1 of 526) of cases; mutations occur in ∼1% (7 of 526) of cases (Figure 1B). Here, FBXO7 is linked to colorectal carcinoma.